Carson Wealth (CWM LLC)’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5K Buy
16,940
+13,700
+423% +$17.4K ﹤0.01% 4433
2025
Q4
$4K Sell
3,240
-212
-6% -$237 ﹤0.01% 4901
2025
Q3
$3K Buy
3,452
+1,491
+76% +$1.63K ﹤0.01% 4909
2025
Q2
$2K Hold
1,961
﹤0.01% 4893
2025
Q1
$3K Hold
1,961
﹤0.01% 4642
2024
Q4
$2K Buy
1,961
+200
+11% +$176 ﹤0.01% 4559
2024
Q3
$1K Hold
1,761
﹤0.01% 4625
2024
Q2
$1K Hold
1,761
﹤0.01% 4412
2024
Q1
$1K Buy
+1,761
New +$2.29K ﹤0.01% 4160
2023
Q4
Sell
-1,920
Closed -$2K 4356
2023
Q3
$2K Hold
1,920
﹤0.01% 3826
2023
Q2
$3K Hold
1,920
﹤0.01% 3658
2023
Q1
$3K Hold
1,920
﹤0.01% 3530
2022
Q4
$3K Sell
1,920
-100
-5% -$180 ﹤0.01% 3427
2022
Q3
$3K Hold
2,020
﹤0.01% 3322
2022
Q2
$5K Buy
+2,020
New +$4.49K ﹤0.01% 2988
2022
Q1
Sell
-200
Closed -$1K 3722
2021
Q4
$1K Buy
+200
New +$1.62K ﹤0.01% 3328

Other funds holding LUCD

Carson Wealth (CWM LLC)'s LUCD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Lucid Diagnostics (LUCD) stake by 423% in Q1 2026, buying an estimated $17.4K and bringing the position to 16,940 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4433.

Carson Wealth (CWM LLC) first reported a position in LUCD in Q4 2021 and has held it in 16 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 16,940 shares of Lucid Diagnostics worth $19.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 13,700 Lucid Diagnostics shares in Q1 2026, an estimated $17.4K.
  • Lucid Diagnostics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4433 holding.
  • Carson Wealth (CWM LLC) first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 16 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.